Clinical Trials
Clinical Trials Overview
This section contains current information about ongoing clinical development programs sponsored by Myrexis, Inc. For more detailed information, please see the specific drug sections as they become available.
| Molecule | Therapeutic Area | Development Stage |
| Azixa™ (verubulin, MPC-6827) | Melanoma | Phase 2 Complete |
| Azixa | Glioblastoma multiforme (GBM) | Phase 2 Ongoing |
| Azixa | GBM (monotherapy) | Phase 2 Ongoing |
| MPC-3100 | Cancer | Phase 1 Recruiting |
For more information on our Azixa™(verubulin, MPC-6827) clinical studies in brain cancer, please visit our website designed to answer your questions
